1	Immunex	_	NNP	_	_	3	SBJ	_	_
2	Corp.	_	NNP	_	_	1	POSTHON	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	its	_	PRP$	_	_	5	NMOD	_	_
5	scientists	_	NNS	_	_	6	SBJ	_	_
6	isolated	_	VBD	_	_	3	OBJ	_	_
7	a	_	DT	_	_	8	NMOD	_	_
8	molecule	_	NN	_	_	6	OBJ	_	_
9	which	_	WDT	_	_	10	SBJ	_	_
10	may	_	MD	_	_	8	NMOD	_	_
11	hold	_	VB	_	_	10	VC	_	_
12	potential	_	JJ	_	_	11	OBJ	_	_
13	as	_	IN	_	_	12	NMOD	_	_
14	a	_	DT	_	_	15	NMOD	_	_
15	treatment	_	NN	_	_	13	PMOD	_	_
16	for	_	IN	_	_	15	NMOD	_	_
17	disruptions	_	NNS	_	_	16	PMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	immune-system	_	NN	_	_	18	PMOD	_	_
21	,	_	,	_	_	17	P	_	_
22	ranging	_	VBG	_	_	17	APPO	_	_
23	from	_	IN	_	_	22	DIR	_	_
24	organ-transplant	_	NN	_	_	25	NMOD	_	_
25	rejection	_	NN	_	_	23	PMOD	_	_
26	,	_	,	_	_	23	P	_	_
27	to	_	TO	_	_	22	DIR	_	_
28	allergies	_	NNS	_	_	27	PMOD	_	_
29	and	_	CC	_	_	28	COORD	_	_
30	asthma	_	NN	_	_	29	CONJ	_	_
31	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	molecule	_	NN	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	mouse	_	NN	_	_	6	NMOD	_	_
6	version	_	NN	_	_	3	PRD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	a	_	DT	_	_	9	NMOD	_	_
9	protein	_	NN	_	_	7	PMOD	_	_
10	called	_	VBN	_	_	9	APPO	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	interleukin-4	_	NN	_	_	13	NMOD	_	_
13	receptor	_	NN	_	_	10	OPRD	_	_
14	.	_	.	_	_	3	P	_	_

1	IL-4	_	NN	_	_	2	SBJ	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	hormone	_	NN	_	_	2	PRD	_	_
5	which	_	WDT	_	_	6	SBJ	_	_
6	directs	_	VBZ	_	_	4	NMOD	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	growth	_	NN	_	_	6	OBJ	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	function	_	NN	_	_	9	CONJ	_	_
11	of	_	IN	_	_	8	NMOD	_	_
12	white	_	JJ	_	_	14	NMOD	_	_
13	blood	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	11	PMOD	_	_
15	involved	_	VBN	_	_	14	APPO	_	_
16	in	_	IN	_	_	15	ADV	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	body	_	NN	_	_	21	NMOD	_	_
19	's	_	POS	_	_	18	SUFFIX	_	_
20	immune	_	JJ	_	_	21	NMOD	_	_
21	response	_	NN	_	_	16	PMOD	_	_
22	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	IL-4	_	NN	_	_	3	NMOD	_	_
3	receptor	_	NN	_	_	10	SBJ	_	_
4	on	_	IN	_	_	3	LOC	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	surface	_	NN	_	_	4	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	such	_	JJ	_	_	9	NMOD	_	_
9	cells	_	NNS	_	_	7	PMOD	_	_
10	receives	_	VBZ	_	_	0	ROOT	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	hormone	_	NN	_	_	14	NMOD	_	_
13	's	_	POS	_	_	12	SUFFIX	_	_
14	message	_	NN	_	_	10	OBJ	_	_
15	to	_	TO	_	_	14	NMOD	_	_
16	rally	_	VB	_	_	15	IM	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	body	_	NN	_	_	20	NMOD	_	_
19	's	_	POS	_	_	18	SUFFIX	_	_
20	defense	_	NN	_	_	16	OBJ	_	_
21	.	_	.	_	_	10	P	_	_

1	But	_	CC	_	_	16	DEP	_	_
2	in	_	IN	_	_	16	ADV	_	_
3	certain	_	JJ	_	_	4	NMOD	_	_
4	conditions	_	NNS	_	_	2	PMOD	_	_
5	such	_	JJ	_	_	6	DEP	_	_
6	as	_	IN	_	_	4	NMOD	_	_
7	autoimmune	_	JJ	_	_	8	NMOD	_	_
8	diseases	_	NNS	_	_	6	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	allergies	_	NNS	_	_	9	CONJ	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	transplant	_	NN	_	_	13	NMOD	_	_
13	rejection	_	NN	_	_	11	CONJ	_	_
14	,	_	,	_	_	16	P	_	_
15	doctors	_	NNS	_	_	16	SBJ	_	_
16	would	_	MD	_	_	0	ROOT	_	_
17	like	_	VB	_	_	16	VC	_	_
18	to	_	TO	_	_	17	OPRD	_	_
19	damp	_	VB	_	_	18	IM	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	immune	_	JJ	_	_	22	NMOD	_	_
22	response	_	NN	_	_	19	OBJ	_	_
23	so	_	IN	_	_	19	PRP	_	_
24	such	_	JJ	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	26	SBJ	_	_
26	do	_	VBP	_	_	23	SUB	_	_
27	n't	_	RB	_	_	26	ADV	_	_
28	touch	_	VB	_	_	26	VC	_	_
29	off	_	RP	_	_	28	PRT	_	_
30	harmful	_	JJ	_	_	32	NMOD	_	_
31	inflammatory	_	JJ	_	_	32	NMOD	_	_
32	reactions	_	NNS	_	_	28	OBJ	_	_
33	or	_	CC	_	_	32	COORD	_	_
34	cell	_	NN	_	_	35	NMOD	_	_
35	destruction	_	NN	_	_	33	CONJ	_	_
36	.	_	.	_	_	16	P	_	_

1	A	_	DT	_	_	3	NMOD	_	_
2	soluble	_	JJ	_	_	3	NMOD	_	_
3	form	_	NN	_	_	7	SBJ	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	receptor	_	NN	_	_	4	PMOD	_	_
7	might	_	MD	_	_	24	OBJ	_	_
8	turn	_	VB	_	_	7	VC	_	_
9	off	_	RP	_	_	8	PRT	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	specific	_	JJ	_	_	12	NMOD	_	_
12	part	_	NN	_	_	8	PRD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	immune	_	JJ	_	_	16	NMOD	_	_
16	response	_	NN	_	_	13	PMOD	_	_
17	without	_	IN	_	_	8	ADV	_	_
18	general	_	JJ	_	_	20	NMOD	_	_
19	immune	_	JJ	_	_	20	NMOD	_	_
20	suppression	_	NN	_	_	17	PMOD	_	_
21	,	_	,	_	_	24	P	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	company	_	NN	_	_	24	SBJ	_	_
24	said	_	VBD	_	_	0	ROOT	_	_
25	.	_	.	_	_	24	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	IL-4	_	NN	_	_	3	NMOD	_	_
3	receptor	_	NN	_	_	4	SBJ	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	one	_	CD	_	_	4	PRD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	five	_	CD	_	_	9	NMOD	_	_
8	such	_	JJ	_	_	9	NMOD	_	_
9	receptors	_	NNS	_	_	6	PMOD	_	_
10	to	_	TO	_	_	9	NMOD	_	_
11	be	_	VB	_	_	10	IM	_	_
12	developed	_	VBN	_	_	11	VC	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	tested	_	VBN	_	_	13	CONJ	_	_
15	by	_	IN	_	_	12	LGS	_	_
16	Receptech	_	NNP	_	_	15	PMOD	_	_
17	Corp.	_	NNP	_	_	16	POSTHON	_	_
18	,	_	,	_	_	16	P	_	_
19	a	_	DT	_	_	20	NMOD	_	_
20	spinoff	_	NN	_	_	16	APPO	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	Immunex	_	NNP	_	_	21	PMOD	_	_
23	,	_	,	_	_	12	P	_	_
24	through	_	IN	_	_	12	MNR	_	_
25	a	_	DT	_	_	32	NMOD	_	_
26	proposed	_	VBN	_	_	32	NMOD	_	_
27	$	_	$	_	_	32	NMOD	_	_
28	30	_	CD	_	_	27	DEP	_	_
29	million	_	CD	_	_	27	DEP	_	_
30	initial	_	JJ	_	_	32	NMOD	_	_
31	public	_	JJ	_	_	32	NMOD	_	_
32	offering	_	NN	_	_	24	PMOD	_	_
33	.	_	.	_	_	4	P	_	_

1	Immunex	_	NNP	_	_	2	SBJ	_	_
2	will	_	MD	_	_	0	ROOT	_	_
3	contract	_	VB	_	_	2	VC	_	_
4	with	_	IN	_	_	3	ADV	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	spinoff	_	NN	_	_	4	PMOD	_	_
7	to	_	TO	_	_	3	PRP	_	_
8	provide	_	VB	_	_	7	IM	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	research	_	NN	_	_	8	OBJ	_	_
11	,	_	,	_	_	10	P	_	_
12	development	_	NN	_	_	10	COORD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	initial	_	JJ	_	_	15	NMOD	_	_
15	testing	_	NN	_	_	13	CONJ	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	the	_	DT	_	_	19	NMOD	_	_
18	new	_	JJ	_	_	19	NMOD	_	_
19	agents	_	NNS	_	_	16	PMOD	_	_
20	.	_	.	_	_	2	P	_	_

1	Immunex	_	NNP	_	_	2	SBJ	_	_
2	will	_	MD	_	_	0	ROOT	_	_
3	have	_	VB	_	_	2	VC	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	option	_	NN	_	_	3	OBJ	_	_
6	to	_	TO	_	_	5	NMOD	_	_
7	buy	_	VB	_	_	6	IM	_	_
8	back	_	RP	_	_	7	PRT	_	_
9	Receptech	_	NNP	_	_	10	NMOD	_	_
10	shares	_	NNS	_	_	7	OBJ	_	_
11	after	_	IN	_	_	7	TMP	_	_
12	five	_	CD	_	_	13	NMOD	_	_
13	years	_	NNS	_	_	11	PMOD	_	_
14	.	_	.	_	_	2	P	_	_

